AU2006250390B2 - 6,7-unsaturated-7-carbamoyl substituted morphinan derivative - Google Patents

6,7-unsaturated-7-carbamoyl substituted morphinan derivative Download PDF

Info

Publication number
AU2006250390B2
AU2006250390B2 AU2006250390A AU2006250390A AU2006250390B2 AU 2006250390 B2 AU2006250390 B2 AU 2006250390B2 AU 2006250390 A AU2006250390 A AU 2006250390A AU 2006250390 A AU2006250390 A AU 2006250390A AU 2006250390 B2 AU2006250390 B2 AU 2006250390B2
Authority
AU
Australia
Prior art keywords
optionally substituted
compound
chiral
lower alkyl
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006250390A
Other languages
English (en)
Other versions
AU2006250390A1 (en
Inventor
Yoshihisa Goto
Nobuhiro Haga
Shin-Ichiro Hara
Tsuyoshi Hasegawa
Masanao Inagaki
Yoshinori Tamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2006250390A1 publication Critical patent/AU2006250390A1/en
Application granted granted Critical
Publication of AU2006250390B2 publication Critical patent/AU2006250390B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2006250390A 2005-05-25 2006-05-25 6,7-unsaturated-7-carbamoyl substituted morphinan derivative Ceased AU2006250390B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2005151864 2005-05-25
JP2005-151864 2005-05-25
JP2006-065762 2006-03-10
JP2006065762 2006-03-10
PCT/JP2006/310231 WO2006126529A1 (ja) 2005-05-25 2006-05-23 ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
AUPCT/JP2006/310231 2006-05-23
PCT/JP2006/310454 WO2006126637A1 (ja) 2005-05-25 2006-05-25 ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体

Publications (2)

Publication Number Publication Date
AU2006250390A1 AU2006250390A1 (en) 2006-11-30
AU2006250390B2 true AU2006250390B2 (en) 2010-07-08

Family

ID=37451954

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006250390A Ceased AU2006250390B2 (en) 2005-05-25 2006-05-25 6,7-unsaturated-7-carbamoyl substituted morphinan derivative

Country Status (20)

Country Link
US (4) US8084460B2 (https=)
EP (1) EP1889848B8 (https=)
JP (1) JP4323547B2 (https=)
KR (1) KR100912782B1 (https=)
CN (1) CN101228172B (https=)
AU (1) AU2006250390B2 (https=)
BE (1) BE2019C533I2 (https=)
BR (1) BRPI0610343B8 (https=)
CA (1) CA2609733C (https=)
DK (1) DK1889848T3 (https=)
ES (1) ES2525215T3 (https=)
FR (1) FR19C1042I2 (https=)
HU (1) HUS1900034I1 (https=)
MX (1) MX2007014588A (https=)
NL (1) NL300996I2 (https=)
PL (1) PL1889848T3 (https=)
PT (1) PT1889848E (https=)
RU (1) RU2403255C2 (https=)
TW (1) TWI311056B (https=)
WO (2) WO2006126529A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006126529A1 (ja) 2005-05-25 2006-11-30 Shionogi & Co., Ltd. ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
EP3090743A1 (en) * 2008-01-09 2016-11-09 Charleston Laboratories, Inc. Pharmaceutical compositions for treating headache and eliminating nausea
JP5252391B2 (ja) * 2008-02-21 2013-07-31 学校法人北里研究所 オキサビシクロ［２．２．２］オクタンを有するモルヒナン誘導体およびその医薬用途
JP5827123B2 (ja) * 2008-09-16 2015-12-02 ウェルズ ファーゴ バンク ナショナル アソシエイション 乱用の可能性が低いｐｅｇ化オピオイド
CA2774021A1 (en) * 2009-09-18 2011-03-24 Adolor Corporation Use of opioid receptor antagonist for gastrointestinal tract disorders
CN102906099A (zh) * 2010-05-13 2013-01-30 株式会社绿十字 作为神经保护剂的基于(+)-3-羟基吗啡喃的多环衍生物
KR101500915B1 (ko) * 2010-11-12 2015-03-10 시오노기세야쿠 가부시키가이샤 6,7-불포화-7-카르바모일 모르피난 유도체의 결정 및 그의 제조 방법
DK2851075T3 (da) 2012-05-14 2022-01-31 Shionogi & Co Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat
US11135217B2 (en) 2016-12-26 2021-10-05 Shionogi & Co., Ltd. Manufacturing process of formulation having improved content uniformity
EP3773573B1 (en) 2018-04-12 2026-03-18 Morphic Therapeutic, Inc. Antagonists of human integrin (alpha4)(beta7)
KR102201609B1 (ko) 2019-04-19 2021-01-12 연성정밀화학(주) 날데메딘의 제조방법
TWI775182B (zh) 2019-10-16 2022-08-21 美商莫菲克醫療股份有限公司 抑制人類整合素αβ
EP4062973A4 (en) 2019-11-20 2023-11-29 Shionogi & Co., Ltd SOLID FORMULATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYL MORPHINAND DERIVATIVE
CN111905111B (zh) * 2020-09-16 2023-03-31 地奥集团成都药业股份有限公司 一种评价复方谷氨酰胺组方对腹泻型肠易激综合征疗效的方法
IT202300009864A1 (it) 2023-05-16 2024-11-16 Procos Spa Processo per la preparazione di naldemedina
CN121534059A (zh) * 2024-08-09 2026-02-17 盐野义有限公司 一种治疗帕金森综合征或帕金森病的方法和药物组合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001037785A2 (en) * 1999-11-29 2001-05-31 Adolor Corporation Novel methods and compositions involving opioids and antagonists thereof
JP2004501094A (ja) * 2000-05-05 2004-01-15 ペイン・セラピューティクス・インコーポレイテッド オピオイドアゴニストの効力を増強するか、またはオピオイドアゴニストの有害な副作用を減弱するための新規な組成物および方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4272541A (en) 1978-06-02 1981-06-09 Miles Laboratories, Inc. 7,8 and 7-8 Substituted 4,5α-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them
US4275205A (en) 1980-05-05 1981-06-23 Miles Laboratories, Inc. 7,7-Ditosyloxymethyl-4,5α-epoxy-morphinan-6-ols
US4347361A (en) 1980-12-10 1982-08-31 Sisa, Incorporated 4,5α-Epoxy-3-hydroxy or methoxy-7-(1-hydroxy-alkyl or 1-oxoalkyl)morphinan-6-one compounds
US4370333A (en) 1981-06-29 1983-01-25 Sisa, Incorporated 17-Cyclopropylmethyl-3-hydroxy-14-methoxy 7α-methyl-morphinan-6-one and therapeutic method of treating pain with it
US4443605A (en) 1982-07-30 1984-04-17 Miles Laboratories, Inc. 7β-Arylalkyl-6α, 7 α-oxymethylene-3-methoxy or 3-hydroxy-4, 5α-epoxy-17 methyl or 17-cycloalkyl-methyl morphinans
US4440932A (en) 1982-09-09 1984-04-03 Miles Laboratories, Inc. 7β-Arylalkyl-7α-methyl-6-oxo or 6α-hydroxy-3-methoxy or 3-hydroxy-4,5α-epoxy-17-methyl or 17-cycloalkyl-methylmorphinans
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
NZ268969A (en) 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
US5464841A (en) 1993-11-08 1995-11-07 Univ Minnesota Use of delta opioid receptor antagonists to treat immunoregulatory disorders
BR9707136A (pt) 1996-01-10 1999-08-31 Smithkline Beecham Spa Derivados morfinóides condesados em heterociclo (ii)
AU5891600A (en) 1999-07-01 2001-01-22 Chemrx Advanced Technologies, Inc. Process for synthesizing oxadiazoles
US6451806B2 (en) * 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US20040024004A1 (en) 2001-05-04 2004-02-05 Sherman Barry M. Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists
JP2004515455A (ja) 2000-05-05 2004-05-27 ペイン・セラピューティクス・インコーポレイテッド オピオイドアンタゴニスト組成物および投薬形態
JP4340437B2 (ja) * 2000-10-31 2009-10-07 レンセラール ポリテクニック インスティチュート ８−カルボキサミド−２，６−メタノ−３−ベンズアゾシン
AU2408602A (en) * 2000-11-22 2002-06-03 Toray Industries Indole derivatives and use thereof in medicines
PL368732A1 (en) * 2001-08-23 2005-04-04 Akzo Nobel N.V. C-14 oxidation of morphine derivatives
DE10161963A1 (de) 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
DE10229842A1 (de) * 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
CN1288158C (zh) 2002-07-11 2006-12-06 东丽株式会社 用于预防恶心和呕吐的治疗剂或预防剂
US7164021B2 (en) * 2002-09-18 2007-01-16 The Curators Of The University Of Missouri Opiate analogs selective for the δ-opioid receptor
US20040157784A1 (en) 2003-02-10 2004-08-12 Jame Fine Chemicals, Inc. Opiod tannate compositions
WO2005105093A2 (en) 2003-08-26 2005-11-10 Duke University METHOD OF ARRESTING THE SIDE EFFECTS OF µ-OPIOID RECEPTOR AGONISTS DURING THEIR ADMINISTRATION
CA2568249C (en) 2004-05-28 2014-12-09 Human Biomolecular Research Institute Synthesis of metabolically stable analgesics, pain medications and other agents
US20060063792A1 (en) 2004-09-17 2006-03-23 Adolor Corporation Substituted morphinans and methods of their use
US7142420B2 (en) 2004-09-20 2006-11-28 Qualcomm, Incorporated Devices and methods for controlling relative movement between layers of an electronic device
WO2006126529A1 (ja) 2005-05-25 2006-11-30 Shionogi & Co., Ltd. ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
KR101500915B1 (ko) 2010-11-12 2015-03-10 시오노기세야쿠 가부시키가이샤 6,7-불포화-7-카르바모일 모르피난 유도체의 결정 및 그의 제조 방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001037785A2 (en) * 1999-11-29 2001-05-31 Adolor Corporation Novel methods and compositions involving opioids and antagonists thereof
JP2003528819A (ja) * 1999-11-29 2003-09-30 アドラー コーポレーション オピオイドおよびそのアンタゴニストに関する新規方法および組成物
JP2004501094A (ja) * 2000-05-05 2004-01-15 ペイン・セラピューティクス・インコーポレイテッド オピオイドアゴニストの効力を増強するか、またはオピオイドアゴニストの有害な副作用を減弱するための新規な組成物および方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FUJII, H. et al., The First Example of the Stereoselective Synthesis of 7-(Beta)-Carbamoyl4,5-(alpha)-epoxymorphinan via a Novel and Reactive y-lactone, Chem. Pharm. Bull., 2004, VoI.52, No.6, pages 747-750 *

Also Published As

Publication number Publication date
NL300996I2 (nl) 2019-07-30
PT1889848E (pt) 2014-12-09
EP1889848B1 (en) 2014-10-15
ES2525215T3 (es) 2014-12-19
KR20080014791A (ko) 2008-02-14
EP1889848A4 (en) 2011-08-10
USRE46375E1 (en) 2017-04-25
BRPI0610343A2 (pt) 2010-06-15
US20090203723A1 (en) 2009-08-13
NL300996I1 (nl) 2019-07-03
AU2006250390A1 (en) 2006-11-30
FR19C1042I2 (fr) 2020-06-19
JP4323547B2 (ja) 2009-09-02
JPWO2006126637A1 (ja) 2008-12-25
US8084460B2 (en) 2011-12-27
USRE46365E1 (en) 2017-04-11
EP1889848A1 (en) 2008-02-20
US8536192B2 (en) 2013-09-17
CA2609733A1 (en) 2006-11-30
TWI311056B (en) 2009-06-21
WO2006126529A1 (ja) 2006-11-30
BRPI0610343B1 (pt) 2020-03-10
WO2006126637A1 (ja) 2006-11-30
TW200726470A (en) 2007-07-16
EP1889848B8 (en) 2014-12-17
HUS1900034I1 (hu) 2019-07-29
KR100912782B1 (ko) 2009-08-18
PL1889848T3 (pl) 2015-04-30
MX2007014588A (es) 2008-01-24
RU2403255C2 (ru) 2010-11-10
CA2609733C (en) 2011-07-19
US20120135978A1 (en) 2012-05-31
FR19C1042I1 (https=) 2019-08-09
BE2019C533I2 (https=) 2025-12-10
DK1889848T3 (en) 2014-12-01
CN101228172A (zh) 2008-07-23
CN101228172B (zh) 2013-04-03
BRPI0610343B8 (pt) 2021-05-25
RU2007148412A (ru) 2009-06-27

Similar Documents

Publication Publication Date Title
AU2006250390B2 (en) 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
LU505464B1 (en) A pan-KRAS inhibitor compound
DE69321525T2 (de) Morphinan-derivate und medizinische verwendung
KR102788843B1 (ko) 스테로이드 유도체 fxr 작용체
JP5383483B2 (ja) アルツハイマー症治療用医薬組成物
US6187782B1 (en) Morphinane derivatives and medicinal use thereof
CN111655682B (zh) 一种高活性sting蛋白激动剂化合物
WO1995003308A1 (fr) Derive de morphinane et application medicale
TR201807321T4 (tr) Farnesoid x reseptörlerinin modüle edilmesi için bileşimler ve yöntemler.
JPWO1995003308A1 (ja) モルヒナン誘導体および医薬用途
JP6605157B2 (ja) デゾシンの類似体
CA2951516A1 (en) Polyene macrolide derivative
US8097610B2 (en) Derivative having PPAR agonistic activity
JP2019508504A (ja) 疾病の処置に有用なｃ−グリコシド化合物
US9932355B2 (en) 2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivatives and use thereof
ES2912740T3 (es) Compuesto heterocíclico y aplicación del mismo en medicina
CA3259558A1 (en) COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS INFECTION
CA3152485A1 (en) Azepane derivative
EP4512797A1 (en) Chiral aryl propionic acid derivative and pharmaceutical composition thereof, and use
EP2463292A1 (en) Compound having neurite-outgrowing activity
EP4062972A1 (en) Pyrazolomorphinan derivative
KR20120108056A (ko) (ｅ)-히드록시이미노페닐아세트산 유도체의 제법
KR20090099886A (ko) 캐스파제 저해제의 프로드럭
JPH04273880A (ja) ジヒドロモルヒネ誘導体
CZ2000459A3 (cs) Krystalický 10,10-bis(2-fluor-4- pyridinyl)methyl)-9(10H)-anthracenon a zlepšený způsob jeho přípravy

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired